Griffin’s 3 Mega-Caps: Buy, Sell, Hold Amid Valuations
Citadel Advisors remains overweight in Microsoft, neutral on Amazon, and cautious on Apple as AI investment cycles di...
Ways To Earn Money While Studying
Earning money while studying is possible with the right strategies. Explore various ways to balance work and academics.
27,524 articles
Anthropic's Potential $1.2 Trillion IPO Could Boost Stock
As Anthropic eyes an IPO, a potential $1.2 trillion valuation could ripple through AI stocks. This piece breaks down ...
Corcept's Selling Plan Month: What Investors Should Know
When a CFO discloses a sizable stake sale during a volatile period, investors scramble for context. This article brea...
Should Amazon Before July: Investor Guide to July Earnings
A thoughtful, real-world guide to deciding whether to buy Amazon before July earnings. Learn how to weigh growth driv...
XME Rally Faces Test as Freeport Recovery Looms Next Quarter
The SPDR S&P Metals & Mining ETF (XME) has surged toward a near-double over the past year, buoyed by gold and copper ...
Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Retirees Face Tax Hit on Your 2026 COLA Increase, Again
The 2026 COLA brings a modest bump to Social Security, but frozen tax thresholds mean a large portion of that gain ma...
Things We’re Doing 2026 to Retire with Rentals
Ready to make rental properties a real pathway to retirement? This guide outlines three actionable strategies for 202...
Down 22%, Should CrowdStrike Stock Be Bought on the Dip?
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
ConocoPhillips Stock Dropped Tuesday: What Investors Need
A Tuesday pullback in COP shares left investors weighing oil prices, broker notes, and the long-term outlook for ener...
Forget Ozempic: This High-Flying Device Maker Stands Strong
In a world obsessed with weight-loss drugs, a different growth engine quietly powers ahead. This article explains why...
Down 25%, Should Bristol Be a Dip Buy Right Now Today?
When a blue-chip pharma stock falls 25%, many investors wonder if it's time to buy. This guide breaks down how to ass...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status